FILTER BY:
Details
MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma
Address: 200 1st St SW, Rochester, MN 55905, USA
Phone: 877-451-7009
Mesothelioma Type:
- Pleural: True
- Peritoneal: False
- Pericardial: False
- Tunica Vaginalis: False
Type: Epitheliod, Sarcomatoid, Biphasic
Condition: Unresectable Pleural Mesothelioma
Description: This is a phase III, randomized, open-label, multicenter, global study to determine the efficacy and safety of Volrustomig (MEDI5752) + Carboplatin + Pemetrexed vs the investigator's choice of platinum + Pemetrexed or Nivolumab + Ipilimumab in participants with unresectable pleural mesothelioma.
Research Center: Mayo Clinic Rochester
Treatment Interventions: DRUG: Volrustomig, DRUG: Pemetrexed, DRUG: Carboplatin, DRUG: Cisplatin, DRUG: Nivolumab, DRUG: Ipilimumab
Potential Impact: Fake Data
Clinical Trial Number: NCT06097728
Phase: Phase 3
Status: Recruiting
